Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Graf Acquisition Corp IV (GFOR)

Graf Acquisition Corp IV (GFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 86,104
  • Shares Outstanding, K 10,374
  • Annual Sales, $ 0 K
  • Annual Income, $ 4,550 K
  • 60-Month Beta 0.03
  • Price/Sales N/A
  • Price/Cash Flow 39.15
  • Price/Book N/A
Trade GFOR with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.01 +65.67%
on 09/28/23
12.88 -35.56%
on 09/19/23
-2.94 (-26.16%)
since 08/29/23
3-Month
5.01 +65.67%
on 09/28/23
12.88 -35.56%
on 09/19/23
-2.02 (-19.57%)
since 06/28/23
52-Week
5.01 +65.67%
on 09/28/23
12.88 -35.56%
on 09/19/23
-1.46 (-14.96%)
since 09/27/22

Most Recent Stories

More News
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting to Approve Business Combination with NKGen Biotech, Inc. to September 25, 2023

/PRNewswire/ -- Graf Acquisition Corp. IV (NYSE: GFOR, GFOR.U, GFOR WS) (the "Company" or "Graf"), announced today that on September 20, 2023, it adjourned,...

GFOR : 8.30 (+5.06%)
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting to Approve Business Combination with NKGen Biotech, Inc. to September 13, 2023

/PRNewswire/ -- Graf Acquisition Corp. IV (NYSE: GFOR, GFOR.U, GFOR WS) (the "Company" or "Graf"), announced today that on September 8, 2023, it adjourned,...

GFOR : 8.30 (+5.06%)
Graf Acquisition Corp. IV and NKGen Biotech, Inc. Announce Letter of Intent for a Business Combination

Graf Acquisition Corp. IV (NYSE: GFOR) (“Graf”), a NYSE-listed special purpose acquisition company founded by serial SPAC founder James Graf, and NKGen Biotech, Inc. (“NKGen Biotech”), a biotechnology...

GFOR : 8.30 (+5.06%)
Graf Acquisition Corp. IV Withdraws Extension Proposal

Graf Acquisition Corp. IV (NYSE: GFOR, GFOR.U, GFOR WS) (the “Company”) today announced that it is withdrawing from the ballot for its special meeting of stockholders to be held on December 21, 2022...

GFOR : 8.30 (+5.06%)
Graf Acquisition Corp. IV Announces Closing of Underwriters’ Over-Allotment Option in Connection with its Initial Public Offering

Graf Acquisition Corp. IV (NYSE: GFOR) (the “Company”) today announced the closing of the issuance of an additional 2,161,500 units pursuant to the partial exercise of the underwriters’ over-allotment...

GFOR : 8.30 (+5.06%)
Graf Acquisition Corp. IV Announces Closing of $150 Million Initial Public Offering

Graf Acquisition Corp. IV (NYSE: GFOR) (the “Company”) today announced that it closed its initial public offering of 15,000,000 units. The offering was priced at $10.00 per unit, resulting in gross...

GFOR : 8.30 (+5.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Graf Acquisition Corp. IV announces business combination agreement with NKGen Biotech Inc.

See More

Key Turning Points

3rd Resistance Point 11.86
2nd Resistance Point 10.65
1st Resistance Point 9.48
Last Price 8.30
1st Support Level 7.10
2nd Support Level 5.89
3rd Support Level 4.72

See More

52-Week High 12.88
Fibonacci 61.8% 9.87
Fibonacci 50% 8.94
Last Price 8.30
Fibonacci 38.2% 8.02
52-Week Low 5.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar